AzTrials
AzTrials

Rotator Cuff TearNCT01767740

Pilot Study of the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff

A study testing ULTRABRAID PLUS SUTURE and ULTRABRAID SUTURE in people with Rotator Cuff Tear, run by Smith & Nephew, Inc. at 4 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this study is to obtain safety data on the use of the ULTRABRAID PLUS SUTURE, and to assess the preliminary effectiveness of the use of the ULTRABRAID PLUS SUTURE in comparison to the ULTRABRAID SUTURE in patients undergoing rotator cuff repair. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Rotator Cuff Tear
What is being tested?
ULTRABRAID PLUS SUTURE and ULTRABRAID SUTURE
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
4 sitesCanada
Study dates
Feb 2013to Nov 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Inclusion Criteria (Subjects must meet ALL of the following criteria):

  • Male or female, aged 18 to 70 years at the time of surgery
  • Willing and able to give voluntary informed consent to participate in this investigation
  • Small (<1cm), Medium (1-3cm) or large (>3-5cm) tear of the supraspinatus tendon, which may or may not include the infraspinatus tendon of the rotator cuff. Tear size will be based on area of longest dimension as evidenced by clinical examination and diagnostic imaging prior to surgery, with the definitive measurement confirmed at surgery
  • Tear requires repair within two years of initial diagnosis
  • Tear must be anatomically repairable (must be able to get tendon back to the medial position on the footprint and at least back to the tuberosity)
  • Willing and able, in the opinion of the Investigator, to cooperate with study procedures, and willing to return to study site for physical therapy and all post-operative study visits

Exclusion Criteria (Subjects must not meet ANY of the following criteria):

  • Tears involving tendons other than the supraspinatus and infraspinatus
  • Partial thickness tears of the rotator cuff (tear must be full thickness)
  • Evidence of acute trauma including fracture or dislocation of the shoulder joint
  • Chronic retraction
  • Evidence of active infection, osteomyelitis, sepsis or distant infection which could spread to the index joint
  • Subject has had previous rotator cuff, arthroplasty or fracture procedures on the operative shoulder
  • Subject has had acromioplasty or diagnostic arthroscopy on the operative shoulder within one (1) year prior to scheduled surgery date
  • Evidence of osteomalacia or other metabolic bone disorder(s) which may impair bone or soft tissue function
  • Evidence of other significant shoulder pathology including (Type II-IV lesion, Bankart lesion, Hill Sachs lesion)
  • Patient has grade 4 changes to articular cartilage in operative shoulder
  • Inflammatory arthropathies
  • Significant muscle paralysis of the shoulder girdle.
  • Painful pathologies of the cervical spine
  • Comminuted bone surface, which would compromise secure anchor fixation.
  • Subject has a known sensitivity to implant materials, including sodium butyrate.
  • Non-surgical rotator cuff associated treatment, such as corticosteroid injection, within one (1) month prior to scheduled surgery date
  • Participating in another investigational trial or ongoing study that would interfere with the assessment of the primary and secondary outcomes
  • Female patient who is pregnant, nursing, or of childbearing potential while not practicing effective contraceptive methods
  • Currently known to abuse drugs or alcohol which could affect follow-up care or treatment outcomes
  • Current smoker
  • Major psychiatric illness, developmental handicap or inability to read and understand the English language
  • Major medical illness that would preclude undergoing surgery
  • Known to be involved in any active injury litigation claims relating to the study shoulder
  • Unwilling or unable to be assessed according to study protocol for one year following surgery
  • Patient requires a concomitant SLAP repair procedure in operative shoulder
  • Surgeon plans to use transosseous sutures in the study procedure
  • Surgeon plans to use a Platelet Rich Plasma product or another therapy intended to augment healing of the rotator cuff in the study procedure
  • Protocol specified surgical technique cannot be followed for this subject
  • Rotator cuff repair will be done via open (as opposed to arthroscopic) procedure
  • Any other reason (in the judgment of the investigator)

Trial locations and contacts

4 sites in 1 country.

Canada4 sites
  • Innovation Science and Medicine

    Burlington, Ontario, L7R 4C7

  • Fowler Kennedy Sport Medicine Clinic

    London, Ontario, N6A 3K7

  • St. Josephs Hospital

    London, Ontario, N6A 4L6

  • Women's College Hospital

    Toronto, Ontario, M5C 1R6

Other trials in Canada

About this study

Official title: Two-Arm, Single Blind, Randomized Pilot Study on the Use of ULTRABRAID PLUS SUTURE in the Repair of Tears of the Rotator Cuff

The primary objective of this study is to obtain safety data on the use of the ULTRABRAID PLUS SUTURE, and to assess the preliminary effectiveness of the use of the ULTRABRAID PLUS SUTURE in comparison to the ULTRABRAID SUTURE in patients undergoing rotator cuff repair.

Read the detailed description

The primary objective of this two-arm, randomized, single-blind pilot study is to obtain safety data on the use of the ULTRABRAID Plus Suture and to assess the preliminary effectiveness of the use of the ULTRABRAID Plus Suture in comparison to the ULTRABRAID Suture in subjects undergoing rotator cuff repair. The primary endpoint of the 6-month postoperative analysis is to assess rotator cuff integrity at 6 months, defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.

Secondary endpoints include:

rotator cuff integrity at the other time points, as well as between arms (1, 3, 6 weeks and 3, 12 months); difference in tissue thickness and muscle atrophy using high-resolution ultrasound between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); difference in tendon echogenicity and vascularity using Doppler ultrasound between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); difference in Constant Shoulder Assessment score and Western Ontario Rotator Cuff (WORC) Index between baseline (preoperative) and all postoperative time points (1, 3, 6 weeks and 3, 6, 12 months); rehabilitation:

  • time to active-assisted rehab exercises
  • time to isometric rehab exercises
  • time to discontinuation of an arm sling lab results (C-Reactive Protein [CRP], Erythrocyte Sedimentation Rate [ESR] and Butyric Acid Levels) at 1, 3, and 6 weeks postoperatively; adverse event (AE) rates (all categories).
Being tested
ULTRABRAID PLUS SUTURE, ULTRABRAID SUTURE
Keywords
Rotator Cuff Tear, Supraspinatus Tear
Medical subject headings
Rotator Cuff Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ULTRABRAID PLUS SUTUREDevice

    Rotator Cuff Repair with ULTRABRAID PLUS SUTURE

  • ULTRABRAID SUTUREDevice

    Rotator Cuff Repair with ULTRABRAID SUTURE

Study groups in NCT01767740
Study groupRoleWhat they receive
ULTRABRAID PLUS SUTUREExperimentalULTRABRAID Plus Suture manufactured by Smith \& Nephew used in subjects undergoing rotator cuff repair.
Receives: Device: ULTRABRAID PLUS SUTURE
ULTRABRAID SUTUREActive comparatorULTRABRAID Suture is a marketed suture manufactured by Smith \& Nephew used in subjects undergoing rotator cuff repair.
Receives: Device: ULTRABRAID SUTURE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rotator Cuff Integrity

    The primary endpoint of the 6-month postoperative analysis is to assess rotator cuff integrity at 6 months, defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.

    Measured: 6 months post-operatively

Secondary outcomes (8)
  1. Rotator Cuff Integrity

    To assess rotator cuff integrity defined as the proportion of subjects with a re-tear of the rotator cuff as measured by high-resolution ultrasound.

    Measured: 1, 3 and 6 weeks and 3 and 12 months post-operatively

  2. Change in post-surgery tissue thickness, rotator cuff integrity, tendon echogenicity and muscle atrophy

    Compared to Baseline (preop)

    Measured: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively

  3. Change in Vascularity

    Compared to Baseline (preop)

    Measured: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively

  4. Change in Constant Shoulder Assessment

    Compared to Baseline (preop)

    Measured: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively

  5. Change in Western Ontario Rotator Cuff Index

    Compared to Baseline (preop)

    Measured: 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively

  6. Rehabilitation

    • Time to active-assisted rehab exercises
    • Time to isometric rehab exercises
    • Time to discontinuation of arm sling

    Measured: 3 and 6 weeks and 3, 6 and 12 months post-operatively

  7. Labs

    Compared to Baseline (preop) Note: If levels do not return to baseline, tests will continue beyond 6 weeks

    Measured: 1, 3 and 6 weeks (optional 3, 6 and 12 months) post-operatively

  8. Adverse Events

    All AE measured and observed, from the initiation of the surgical procedure and throughout the subjects participation in the study, were recorded.

    Measured: Surgery and 1, 3 and 6 weeks and 3, 6 and 12 months post-operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2013 (estimated)
  2. Study startFeb 2013
  3. Primary completionNov 2016
  4. Study completionNov 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01767740
Sponsor's protocol ID
15001105
Status last verified
Oct 2017
First submitted
9 Jan 2013
Last updated
6 Oct 2017
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing ULTRABRAID PLUS SUTURE and ULTRABRAID SUTURE in people with Rotator Cuff Tear, run by Smith & Nephew, Inc. at 4 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rotator Cuff Integrity (time frame: 6 months post-operatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in